Stockholders' Equity - Additional Information (Details) - USD ($)				3 Months Ended
	Mar. 10, 2023	Feb. 28, 2023	Jan. 25, 2023	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Stockholders' Equity
Common stock, shares authorized				90,000,000		90,000,000
Common Stock, par value				$ 0.0001		$ 0.0001
Preferred stock, shares authorized				6,000,000		6,000,000
Preferred stock, par value				$ 0.0001		$ 0.0001
Net proceeds (in shares)				1,299,947
Stock-based compensation				$ 819,064	$ 908,987
Unrecognized stock - based compensation expense				$ 3,228,544
Weighted average period of recognition				1 year 7 months 6 days
Stock-based compensation				$ 819,064	908,987
Number Of Shares Issued Upon Exercise Of Stock Options			19,530
Cashless exercise of stock options (in shares)			73,334
Net proceeds				3,500,000
Securities purchase agreement
Stockholders' Equity
Net proceeds (in shares)	250,000
Research and Development Expense.
Stockholders' Equity
Stock-based compensation				501,181	375,130
General and Administrative Expense
Stockholders' Equity
Stock-based compensation				443,934	$ 407,806
Restricted stock units
Stockholders' Equity
Resignation of common stock RSU		3,289
Unrecognized stock - based compensation expense				$ 62,079
Weighted average period of recognition				3 months 18 days
Options
Stockholders' Equity
Weighted average estimated grant date fair value				$ 1.61	$ 2.28
Common Stock
Stockholders' Equity
Resignation of common stock RSU				3,289	19,359
Cashless exercise of stock options (in shares)				19,530